Feedback / Questions
CHM-029 - CHARM Therapeutics
https://www.globenewswire.com/news-release/2025/11/13/3187132/0/en/CHARM-Therapeutics-advances-CHM-029-a-next-generation-menin-inhibitor-designed-to-overcome-resistance-mutations-as-its-first-clinical-candidate-for-acute-myeloid-leukaemia-AML.html
 
Nov 13, 2025
 
SHARE THIS
  • Print
  • Email
  • More sharing
    Reddit
    StumbleUpon
    Delicious